Flinton Capital Management’s ResMed RMD Stock Holding History

Flinton Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$707K	Sell	5,236 -952	-15%	-$125K	0.02%	369
2019 Q2	$755K	Sell	6,188 -1,176	-16%	-$130K	0.02%	368
2019 Q1	$766K	Buy	7,364 +2,044	+38%	+$211K	0.03%	354
2018 Q4	$606K	Sell	5,320 -896	-14%	-$96K	0.02%	371
2018 Q3	$717K	Sell	6,216 -140	-2%	-$15.3K	0.02%	394
2018 Q2	$658K	Buy	6,356 +196	+3%	+$19.8K	0.02%	379
2018 Q1	$607K	Sell	6,160 -448	-7%	-$42.3K	0.02%	375
2017 Q4	$560K	Buy	6,608 +504	+8%	+$41.6K	0.02%	404
2017 Q3	$470K	Sell	6,104 -8,400	-58%	-$643K	0.02%	408
2017 Q2	$1.13M	Buy	14,504 +4,480	+45%	+$321K	0.04%	256
2017 Q1	$721K	Sell	10,024 -3,108	-24%	-$215K	0.03%	312
2016 Q4	$815K	Buy	+13,132	New	+$804K	0.04%	258

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Flinton Capital Management's RMD Position: Q3 2019 in Review

Flinton Capital Management reduced its ResMed (RMD) stake by 15% in Q3 2019, selling an estimated $125K and leaving 5,236 shares worth $707K. The position accounts for 0.02% of the portfolio, ranked #369.

Flinton Capital Management first reported a position in RMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.13M in Q2 2017. 527 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

Flinton Capital Management held 5,236 shares of ResMed worth $707K as of Q3 2019.
Flinton Capital Management sold 952 ResMed shares in Q3 2019, an estimated $125K.
ResMed made up 0.02% of Flinton Capital Management's portfolio in Q3 2019, its #369 holding.
Flinton Capital Management first reported a position in ResMed in Q4 2016 and has held it in 12 quarters since.
Flinton Capital Management's ResMed position peaked at $1.13M in Q2 2017.
527 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.